Latest News about ATAI
Recent news which mentions ATAI
Allied, Cybin Among Top Psychedelic Movers Of Today
February 10, 2022
From Benzinga
21 Stocks Moving in Thursday's Pre-Market Session
February 10, 2022
From Benzinga
Cathie Wood Sells Yet Another $12M In Twitter Shares Ahead Of Social Media Company's Q4 Earnings Report
February 10, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From February 9, 2022
February 09, 2022
From Benzinga
Why Shares of Mind Medicine Jumped 13.4% on Wednesday
February 09, 2022
From Motley Fool
From Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
February 08, 2022
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
February 07, 2022
From Benzinga
Is The Psychedelics Sector In Decline? This $30M VC Fund Says HOLD
February 07, 2022
From Benzinga
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
February 04, 2022
From Benzinga
From Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
February 02, 2022
From Benzinga
New Psychedelics ETF Launches On NYSE Arca
February 02, 2022
From Benzinga
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today
February 01, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 28, 2022
January 28, 2022
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
January 27, 2022
Tickers
ATAI
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
January 26, 2022
From Benzinga
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
January 25, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
January 24, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 21, 2022
January 21, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2022
January 17, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.